Catalyst Wire Dossier Catalyst Wire Dossier

Tanimilast

tanimilast · Chiesi Farmaceutici S.p.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tanimilast, covering 2025-12-18 to 2025-12-18. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Tanimilast in Asthmatics uNcontrolled on ICS-containinG backgrOund Maintenance Therapy [Phase 2]

See pricing